bromo, were well tolerated to these conditions. These char-
acters would allow diversity synthesis of N,N-diaryl hydra-
zides. Indeed, by employing some functionalized N-phenyl
hydrazides, neurokinin receptor antagonist 4p (entry 17),1
cell harm inhibitor 4q (entry 18),2 and compound 4r (entry
19), that is useful for the treatment of thrombolic disease,4
were effectively prepared.
1-substituted 3-methylindazoles (entries 1ꢀ7). The yields
are generally excellent except for a nitro-substituted pro-
duct, which might probably result from the poor nucleo-
phility of the corresponding N-aryl hydrazide. The similar
problem was observed when a pyridine-embodied sub-
strate was utilized (entry 8). It seemed that electronic
nature of aryl bromides has little influence to this process,
as evident from the 11j and 11k that were obtained in
similar yields (entries 9 and 10). Further investigations
indicated that the method was amenable to 1-(2-bromo-
pyridin-3-yl)ethanone (entry 11) and 2-bromophenyl-
acetone with different R-substituents (entries 12ꢀ16),
although in some cases the yields were not so satisfactory.
In conclusion, we have discovered a convenient method
for assembling N,N-disubstituted hydrazines, which relies
on a CuI-catalyzed coupling of aryl iodides with N-acyl-
N0-substituted hydrazines. We also revealed that CuI/4-
hydroxy-L-proline catalyzed coupling of aryl hydrazides
with 2-bromoarylcarbonylic compounds worked under
mild conditions, thereby providing a facile method for
preparing 1-aryl-1H-indazoles. Various functional groups
were found to tolerate these reaction conditions, and
therefore these methods may find applications in organic
synthesis.
When 4-bromoanisole was utilized as coupling partner,
poor conversion was observed even at 140 °C (Scheme 1).
Using 4-hydroxy-L-proline as a promoter could help the
coupling, but the reaction yield was still poor. However,
CuI/4-hydroxy-L-proline catalyzed coupling of 2-bromo-
phenyl-acetone 6a with 2a could complete at 60 °C to
afford N-aryl hydrazide 7 with a good yield in either DMSO
or dioxane. This result implied that there is an ortho-
substituent effect18 directed by an acyl group in this case.
This hypothesis was further supported by poor conversion of
4-bromophenylacetone 8 to 4c even at 130 °C and exclusive
formation of N-aryl hydrazide 9 from dibromide 6b.
The easy coupling of 2-bromoarylcarbonylic compounds
caused by their ortho-acyl groups prompted us to design a
one-pot reaction process for preparing 1-aryl-1H-inda-
zoles, a class of biologically important heterocycles.19,20
As outlined in Scheme 2, we believed that the coupling
products could undergo deprotection and subsequent
intramolecular condensation to afford 1-aryl-1H-inda-
zoles. After some attempts, we found that formation of
3-methyl-1-phenyl-1H-indazole 11a from 6a could be
achieved by adding HOAc after coupling reaction was
completed.
Acknowledgment. The authors are grateful to the Chinese
Academy of Sciences, National Natural Science Foun-
dation of China (grants 20921091 and 20572119) and
Ministry of Science and Technology (grant 2009CB940900)
for their financial support.
This one-pot reaction process was then checked by
varying aryl bromides and N-aryl hydrazides. As summar-
ized in Table 3, a number of N-aryl hydrazides bear-
ing either electron-donating or electron-withdrawing
groups could be used for obtaining the corresponding
Supporting Information Available. Experimental proce-
dures and copies of 1H NMR and 13C NMR spectra for
all new products. This material is available free of charge
(18) (a) Cai, Q.; Zou, B.; Ma, D. Angew. Chem., Int. Ed. 2006, 45,
1276. (b) Xie, X.; Chen, Y.; Ma, D. J. Am. Chem. Soc. 2006, 128, 16050.
(c) Zhao, H.; Fu, H.; Qiao, R. J. Org. Chem. 2010, 75, 3311. (d) Xu, W.;
Jin, Y.; Liu, H.; Jiang, Y.; Fu, H. Org. Lett. 2011, 13, 1274.
(19) (a) Zhang, X. Q.; Song, F. B.; Kuo, G. H.; Xiang, A.; Gibbs,
A. C.; Abad, M. C.; Sun, W. M.; Kuo, L. C.; Sui, Z. H. Bioorg. Med.
Chem. 2011, 21, 4762. (b) Chen, H.; Kuo, S.; Teng, C.; Lee, F.; Wang, J.;
Lee, Y.; Kuo, C.; Huang, C.; Wu, C.; Huang, L. Bioorg. Med. Chem.
2008, 16, 1262. (c) Bharate, S. B.; Mahajan, T. R.; Gole, Y. R.; Nambiar,
M.; Matan, T. T.; Almeida, A. K.; Balachandran, S.; Junjappa, H.;
Balakrishnan, A.; Vishwakarma, R. A. Bioorg. Med. Chem. 2008, 16,
7167. (d) Dessole, G.; Branca, D.; Ferrigno, F.; Kinzel, Q.; Muraglia, E.;
Palumbi, M. C.; Rowley, M.; Serafini, S.; Steinkuhler, C.; Jones, P.
Bioorg. Med. Chem. Lett. 2009, 19, 4191.
(20) For previous synthetic studies, see: (a) Song, J. J.; Yee, N. K.
Org. Lett. 2000, 2, 519. (b) Song, J. J.; Yee, N. K. Tetrahedron Lett. 2001,
42, 2937. (c) Lebedev, A. Y.; Khartulyari, A. S.; Voskoboynikov, A. Z. J.
Org. Chem. 2005, 70, 596. (d) Cho, C. S.; Lim, D. K.; Heo, N. H.; Kim,
~
T. J.; Shim, S. C. Chem. Commun. 2004, 104. (e) Vina, D.; Olmo, E. D.;
ꢁ
ꢁ
Lopez-perez, J. L.; Feliciano, A. S. Org. Lett. 2007, 9, 525. (f) Spiteri, C.;
Keeling, S.; Moses, J. E. Org. Lett. 2010, 12, 3368. (g) Jin, T.; Yamamoto,
Y. Angew. Chem., Int. Ed. 2007, 46, 3323. (h) Stambuli, J. P.; Wray, B. C.
Org. Lett. 2010, 12, 4576. (i) Liu, R.; Zhu, Y.; Qin, L.; Ji., S. Synth.
Commun. 2008, 38, 249. (j) Gao, M.; Liu, X.; Wang, X.; Cai, Q.; Ding, K.
Chin. J. Chem. 2011, 29, 1199.
The authors declare no competing financial interest.
D
Org. Lett., Vol. XX, No. XX, XXXX